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The phenomenon  of immunologic tolerance has  been  known  for more than 
20 yr, yet its mechanism remains obscure and difficult to study. One reason for 
this is that substances able to induce tolerance generally also induce an inmlune 
response,  thus  confusing  the  issue.  If  a  "pure"  tolerance-inducing substance 
were available, it would provide a basis for isolating and analyzing the phenom- 
ena of tolerance and immunity as separate events. In this paper we will show 
that a hapten (dinitrophenyl [DNP])1 bound to a nonimmunogenic carrier meets 
the  requirement  of  a  pure  tolerogen  in  that  it  can  induce  tolerance without 
causing  antibody synthesis.  This  extends  our  preliminary observation that  a 
hapten  bound  to  a  nonimmunogenic  protein  carrier induces  tolerance  to  the 
same hapten bound to an immunogenic protein carrier (1). The data show that 
the key to  this  capability rests with  the  carrier moiet.y of the hapten-carrier 
conjugate. 
Materials and Methods 
Animals.--6-7-wk  old male  (C57BL/6J  X  DBA/2)F1  (hereafter  referred  to as BDF1), 
C57BL/6J,  and BALB/c mice were used.  All animals were obtained from Jackson Labora- 
tories, Bar Harbor, Maine. 
* These studies were supported by U. S. Public Health Service grants number AI 09825-01 
from  the Immunology Branch,  the National Institute of Allergy and  Infectious Disease; 
AM 07937 from the National Institute of Arthritis and Metabolic Disease; and in part  by 
grant No. 7-32 from The Massachusetts Chapter of the Arthritis Foundation. 
Postdoctoral fellow on leave of absence from Israel defense forces. 
§ Scholar of the Leukemia Society of America. 
I Abbreviations used in this paper: Alb, albumin; BDF1,  (C57BL/6J  X DBA/2)F1; BSA, 
bovine  serum  albumin;  CFA,  complete Freund's adjuvant;  DNFB,  1-fluoro-2,4-dinitro- 
benzene;  DNP,  dinitrophenyl(ated); DNPS,  2,4-dinitrophenyl sulfonic  acid; DNP-serum, 
DNP-C57BL/6;  eACA,  eaminocaproic  acid; HGG, human gamma globulin; HRBC,  horse 
red blood cells; IgG, 7S immunoglobulin;  IgM,  19S immunoglobulin;  KLH, keyhole limpet 
hemocyanin; MGG,  mouse  gamma globulin;  MSA,  mouse  serum  albumin; PFC,  plaque- 
forming  cells; RGG, rabbit gamma globulin;  SRBC,  sheep  red  blood  cells; TNBS,  2,4,6- 
trinitrobenzene sulfonic acid; TNP,  trinitrophenyl. 
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Haptens.--2,4-Dinitrophenyl sulfonic acid (DNPS), twice recrystallized (Eastman Kodak 
Co.,  Rochester,  N.  Y.),  1-fluoro-2,4-dinltrobenzene  (DNFB)  (Eastman  Kodak  Co.),  and 
picryl sulfonic acid  (2,4,6-trinitrobenzene sulfonic  acid, TNBS)  (Nutritional Biochemicals 
Corp., Cleveland, Ohio), twice recrystaUized, were used. 
Protein Carriers.- 
Keyhole limpet hemocyanln (KLH): Obtained from Pacific Bio Marine Supply Co., Venice, 
Calif., and prepared according to the method of Campbell (2). 
Mouse serum (C57BL/6Y):  Purchased from Jackson Laboratories, Bar Harbor, Maine. 
Mouse Serum  Fractions.--19S  immunoglobulin (IgM)  was  obtained by chromatographic 
separation of C57BL/6J  serum on Sephadex  G-200  (Pharmacia Fine Chemicals,  Inc., Pis- 
cataway, N. J.). 7S immunoglobulin (IgG) and albumin (Alb) were prepared by starch block 
electrophoresis of  C57BL/6J serum. The purity of these three fractions was tested by im- 
munoelectrophoresis using a rabbit anti-whole mouse serum. Rabbit gamma globulin (RGG). 
(Pentex Biochemical, Kankakee, Ill.) and human gamma globulin (HGG)  (Pentex Biochem- 
ical)  were  further purified  by diethylaminoethyl  (DEAE)  chromatography.  Bovine  serum 
albumin (BSA) was obtained from Armour Pharmaceutical Co., Chicago, Ill. 
Synthetic  Antigens.~-DNP-lysine  (lys)5,  ~-DNP-(lys)~,  and  o~-DNP-(lys)31  were  a 
gift of Dr. Stuart Schlossman. 
Preparation of Conjugates.--DNPS  was bound to protein carriers according to the method 
of Eisen (3). The preparations of DNP-C57BL/6 serum (hereafter referred to as DNP-serum) 
used to induce tolerance, unless otherwise mentioned, contained 14-23 moles of DNP/mole 
of serum (1  X  l0  b was arbitrarily chosen as the average molecular weight of serum protein). 
To study the dose relationship between hapten and serum protein carrier, the conjugates of 
DNP-serum used ranged from DNP1- to DNP61-serum.  In the case of DNP-KLH,  either 
DNPS  or DNFB  was used and the molar ratios of DNP:KLH  ranged from DNP29-KLtt 
to DNP246-KLH  (assuming the mol wt of KLH to be 8 X  10b).  TNBS was bound to KLH or 
to isogenelc mouse serum according to the method of Rittenberg (4)  (TNPt01-KLH,  TNP4~- 
serum). 
Immunlzation.--This was always done at 7 wk of age. When the primary immune response 
was tested by the hemolytic plaque assay, a  single intraperitoneal injection of 1 mg of either 
DNP246-KLH  or DNPI01-KLH  was given. When DNP62-KLH was used,  each mouse was 
given 0.2 rag.  During the course of the experiments it was found that challenging doses of 
0.2 mg/mouse and 1 rag/mouse of DNP-KLH  elicited similar immune responses. Therefore, 
0.2 mg of DNP-KLH was chosen as the immunizing dose. Furthermore, there were no dif- 
ferences in splenic plaque-forming cells (PFC) in mice challenged with preparations of DNP- 
KLH  varying from  62  moles/mole  to  246  moles/mole.  All  other  DNP  conjugates,  when 
used for immunization, were given in a dose of 0.2 rag/mouse. When trinitnophenyl (TNP) 10t- 
KLH was used for eliciting a primary response, the dose was also 0.2 mg/mouse. All challenges 
with  DNP  or  TNP  conjugates were  administered intraperitoneaIly in  complete  Freund's 
adjuvant  (CFA). 
When the autigenicity of  the various DNP  conjugates was  tested, groups  of  BDF1  or 
BALB/c mice were injected intraperitoneally three times at  intervals of  2  wk with DNP 
conjugates in CFA in a dose of 0.05-0.15 rag/mouse. Serum from each mouse was collected 
by three to four repeated bleedings (at 2-day intervals) from the tail starting 3 days after the 
last  antigenic challenge and pooled.  In some experiments animals were  immunized simul- 
taneously with DNP-KLH  and 0.1 ml of a  10% suspension of washed horse red blood cells 
(HRBC)  (Baltimore Biological Laboratories,  Cockeysville,  Md.). 
Induction  of Tolerance.--This  was done by a  single intravenous injection of 0.3-5.0  mg/ 
mouse of DNP-serum.When synthetic polypeptide conjugates were used, 4-5 daily intraven- 1048  NONANTIGENICITY  AND  IMMUNOLOGIC TOLERANCE 
ous injections of 0.25  rag/mouse were given. For all other conjugates the dose was 0.2 rag/ 
mouse. 
Spleen Cell Suspension.--Spleens  were excised,  weighed, and  minced with scissors.  The 
fragments were gently pressed through a  tantalum gauze into 5 ml of tissue culture media 
(TCM 858, Difco Laboratories, Detroit, Mich.). Nucleated cell counts were made for each 
spleen suspension by using a hemocytometer. 
Hemolytic Plaque Assay.--The method described by Rittenberg using TNP-coated sheep 
red  blood cells  (SRBC)  (Colorado  Serum  Co.,  Denver,  Colo.)  for the detection of direct 
plaque-forming cells was used (5). 
Passive Hemagglutination.--A  modification of the micromethod of Heller et al.  was used 
(6). DNP60-BSA was used to coat the tanned SRBC. 
Radioactive Antigen-Binding Immunocs'say.--A  modification of Farr's technique, described 
by Green et al., was used (7). DNP-e-aminocaproic acid (eACA)-3H  was a gift of Dr. Stuart 
Schlossman. In preliminary experiments, various concentrations  of  DNP-eACA-3tt  (5  X 
10  -6  M to  5  X  10  -9  M)  and  various dilutions of the antisera  (1/10-1/800)  were used  to 
determine the amount of antigen that provided the most sensitive assay of murine anti-DNP 
antibody. These were found to be 5  X  10  -s M of  DNP-eACA3H  (specific activity of  1 
/~Ci/5  X  10  -8 M) and a dilution of serum of 1/i00. To relate the percentage of antigen binding 
to actual amounts of anti-DNP antibody, the assay was calibrated with sera containing known 
amounts of anti-DNP  antibody.  This  disclosed that  the lower limit  of sensitivity of the 
assay was 0.002  mg of antibody at 30%  binding. 30%  antigen binding was chosen as the 
lower limit for reliable results, since the 95%  confidence limit for nonspecific  binding was 
24%. The binding values of serum from normal (nonimmunized) animals ranged from 0-8%. 
Statistical Analysis.--Statistlcal  analysis was done according to Student's t test. For PFC, 
the geometric mean for each group was calculated. 
RESULTS 
Induction of Immunological Tolerance to DNP by DNP-Serum.--At various 
times before or after challenge with DNP-KLH,  different groups of BDF1 mice 
were given a single intravenous injection of DNP14-serum. The immune response 
of these animals to DNP was assayed 5 days after challenge with DNP-KLH. 
The results are shown in Fig.  1. Tolerance was induced in less than 24 hr, and 
lasted between 2  and 3  wk. The immune response of the group injected with 
DNP-serum 3 wk before the challenge with DNP-KLH was not different from 
that  of  the  control  group  (P  >  0.05).  When  DNP-serum  was administered 
1 day after immunization with DNP-KLH,  tolerance of DNP  developed; how- 
ever,  tolerance was not found when DNP-serum was given 3  or 4  days  after 
challenge with DNP-KLH.  Since in the latter cases the DNP-serum was given 
48 or 24 hr before the assay for PFC, the results support our previous observa- 
tion  that  DNP-serum  does  not  "mask"  the  immune response by  binding  to 
antibody-forming cells (1). 
Since  tolerance  of DNP  induced  by DNP-serum  was  lost after 3  wk,  two 
groups of mice were given 2.5 mg of DNPwserum. 3 wk later one group received 
a  second injection  of 2.5  mg  of DNPwserum,  and  the  other group  received 
nothing.  At  that  time  both  groups  were  challenged  with  DNP-KLH.  The 
number of PFC in the group injected twice with the tolerogen was 3.4 ±  0.6 DOV  THEO  GOLAN  AND  YVES  BOREL  1049 
PFC/106 spleen cells, whereas the group injected once had 99.7 +  23.3 PFC/106 
spleen cells. It thus appeared that tolerance of DNP  could be maintained by 
repeated doses of the tolerogen. 
The Dose of Hapten or Carrier Required to Induce Tolerance  to DNP.--In the 
first series of experiments, the amount of the carrier was kept constant (2.5 mg 
of serum  protein/mouse)  and  the  amount  of  the hapten  was  varied.  In  the 
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FIO.  1.  Induction  and duration  of immunological tolerance to D2VP-serum. The  upper 
shaded area represents the number of direct PFC -4- sE to DNP in 14 control mice challenged 
with 1 mg of DNPIsg-KLH intraperitoneally in CFA. The lower shaded area represents the 
number of direct PFC ~  sE to DNP in groups of mice (6-10 in each) immunized with 1 mg 
of KLH intraperitoneally in CFA. Each point represents the geometrical mean -4- sE of the 
number of direct PFC to DNP obtained in mice injected intravenously with a single dose 
of 2.5 mg of DNP14-serum/mouse  at various days before or after challenge with 1 mg of 
DNPlsg-KLH. 
second series of experiments, the amount of the hapten was kept constant (14 
moles of hapten/100,000 mol wt protein) and the amount of the carrier (mouse 
serum)  was varied. In all cases the experimental animals were given a  single 
injection of DNP-serum 8 days before challenge with DNP-KLH.  The results 
(Fig. 2)  show that when DNP  was bound to whole serum,  at least 7 moles of 
hapten/100,000  mol wt of serum protein were necessary to induce tolerance of 
DNP. A dose of 0.6 mg/mouse of whole isogeneic serum (the carrier) was neces- 
sary to induce tolerance. 
Haplen Specificity of Tolerance.--Several  attempts were made to coat sheep 1050  NONANTIGENICITY  AND  IMMUNOLOGIC  TOLERANCE 
red cells with DNP,  either by coating them directly (8, 9)  or by coating them 
with DNP bound to a  protein carrier (10)  in order to measure anti-DNP PFC 
in animals immunized with DNP-KLH.  The results were inconsistent and the 
number of direct PFC  detectable was always about 8-10-fold lower than  that 
obtained with TNP-SRBC.  These methods were therefore abandoned and for 
technical efficiency TNP was used to coat the target sheep red cells. In view of 
the  fact  that  the  immune  response  was  tested  in  a  cross-reacting  system, 
several  questions  arose  concerning  both  immunity  and  the  specificity  of 
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FIG. 2.  Hapten  carrier  (isogenic serum)  relationship  in  induction  of tolerance by  DNP- 
serum.  Left panel: Dose of carrier (2.5 mg of serum proteln/mouse) was kept constant. The 
degree of substitution of DNP varied (I)NPl-serum to DNP61-serum).  Right panel: :Dose of 
hapten  (14 moles/100,000 mol wt serum protein) was kept constant. The amount of carrier 
varied (0.3-5.0 rag/mouse). The upper shaded area represents  the normal primary immune 
response; the lower shaded bar, the background  response in BDF1 mice immunized with the 
carrier (KLH) alone. Each point represents  the geometrical mean of the result in groups of 
six to eight experimental  mice that were pretreated with a  single injection of DNP-serum 
intravenously 8 days before challenge with DNPlag-KLH. The vertical bars represent  1 sE. 
tolerance.  (a)  Would  immunization  with  TNP-K_LH  instead  of  DNP-KLH 
result in a  greater number  of direct PFC  to TNP?  (b)  Do all the direct PFC 
elicited  by  DNP-KLH  cross-react  with  TNP  on  the  target  SRBC?  When 
preparations of DNP62-KLH  and TNP101-KLH  were used to  immunize mice, 
similar numbers of direct PFC were obtained when the assay was carried out 
using TNP-SRBC  (Fig. 3). Since direct assay for DNP-PFC  is unsatisfactory, 
the possibility remains that the TNP assay does not reveal all PFC responding 
to DNP. However, the number of PFC elicited by DNP-K_LH was the same as 
the  one  elicited by TNP-KLH,  suggesting  that  most  of  the  anti-DNP  anti- 
body  cross-reacts  with  TNP-SRBC. DOV  THEO  GOLAN  AND  YVES  BOREL  1051 
The next series of questions concerns the hapten specificity of the induction 
of tolerance: Would tolerance to a hapten be obtained in a homologous system? 
The  results  show  that  animals  injected  intravenously  with  TNP-serum  and 
then challenged with TNP-KLH were tolerant to TNP-SRBC (Fig. 3). Thus, 
we were not suppressing only the anti-DNP antibody cross-reacting with TNP. 
The results  also show that,  when the immune response was tested in a  cross- 
reacting system (i.e. challenged with DNP-KLH and tested with TNP-SRBC), 
tolerance is induced equally well by DNP-serurn  or TNP-serurn.  Finally,  the 
question arose as to whether hapten  specificity can be revealed when  the im- 
mune response is tested in a  non-cross-reacting system. Tolerance in animals 
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FIG. 3. ttapten specificity (DNP and TNP) of the immune response and tolerance. Shaded 
columns represent  groups of BDFI mice (8-10/group)  challenged with 0.2 mg of DNPs2- 
KLH/mouse. Black columns represent groups of mice (8-10/group)  challenged with 0.2  nag 
of TNYlsl-KLH/mouse. At the bottom of the column is indicated which haptens were used: 
those before the bar represent the hapten bound to isogeneic serum conjugate used 2.5 nag/ 
mouse to induce  tolerance  (DNPss-serum, TNP47-serum), and those after the bar represent 
the hapten-KLH conjugate used to challenge the animal. All animals were challenged with 
DNP  or TNP-KLH immediately  after pretreatment  intravenously  with  tolerogen.  In all 
experiments the direct PFC were tested with target SRBC coated with TNP. The vertical 
bar represents 1 sE. 
treated with TNP-serum and challenged with TNP-KLH was more profound 
(P  >  0.001)  than  in  animals  treated  with  DNP-serum  and  challenged  with 
TNP-KLH. This may reflect the immunochemical specificity of the tolerance, 
since the target  SRBC in both cases was TNP-SRBC. 
The Role of Isologous Serum Proteins in the Induction of Tolerance to DNP.-- 
Thus far, we have seen that DNP bound to whole serum can induce tolerance 
of DNP.  In order to determine  their  roles as carriers in this  system, purified 
IgM,  IgG,  and  albumin  were  prepared  and  conjugated  to  DNP.  The  final 
preparations  had  a  similar  degree  of  hapten  substitution,  and  they  were 
compared for  their  capacity to induce tolerance  both  on a  weight  (Table  I) 
and a molar basis (Table II). IgG was superior as a carrier for the induction of 
tolerance  to  both  of  the  other  proteins.  Another  experiment  was  done  to 1052  NONANTIGENICITY AND  IMMUNOLOGIC TOLERANCE 
determine  if  lightly  substituted  albumin  would  be  more  tolerogenic  than 
DNPls-albumin.  A group of five mice was injected intravenously  with 0.2 mg of 
DT~Pg-albumin and  challenged  with  DNP-KLH  in  CFA.  The  geometrical 
mean of PFC/106 spleen cells was (134.9 ±  25.7), which is not different from 
TABLE I 
Induction of Tolerance  to DNP by DNP Bound to Isogeneic Protein Carriers* 
No. of mice  Tolerogen  Direct PFC/10~ (4- sE)  P 
BDF1 
10  None  95.1  (17.2) 
8  DNP12-IgG  4.1  (0.5)  <0.01, 
8  DNPI4-IgM  41.0  (8.9)  <0.001§ 
11  DNPls-Alb  31.4  (3.3)  <0.001§ 
C57BL/6 
4  None  102.5  (15.3) 
6  DNP12-IgG  5.2  (1.7)  <0.0015 
7  DNP23-AIb  99.7  (23.3)  <0.001§ 
* Background  PFC/106  spleen cells in nonimmunized BDF1  and C57BL/6  mice were 
4.0  (:t:0.7)  and 2.1  (+0.17), respectively. All mice  were challenged with 0.2 mg of DNP62- 
KLH in CFA intraperitoneally.  Experimental mice received 0.2 mg of the tolerogen intra- 
venously immediately before being challenged with the antigen intraperitoneally. 
Compared to immunized control mice. 
§ Compared to DNP-IgG experimental mice. 
TABLE II 
Induction of Tderauce to DNP by DNP Bound to Isogendc Protein Carriers* 
No. of BDF1 mice  Tolerogen  Direct PFC/10~ (4- sE)  P 
10  None  95.1  (17.2) 
9  DNPI~-IgG  4.9  (0.3)  <0.001~ 
4  DNP14-IgM  16.9  (7.0)  <0.001§ 
9  DNPls-Alb  32.0  (4.3)  <0.001§ 
* Background PFC/106 spleen cells in nonimnmnized BDFI mice were 4.0  (4-0.7). All 
mice were challenged with 0.2 mg of DNP62-KLH in CFA intraperitoneally.  Experimental 
mice received 1.4  X  10  -6 ~  of the tolerogen intravenously immediately before being chal- 
lenged with antigen intraperitoneally. 
Compared to immunized control mice. 
§ Compared to DNP-IgG pretreated  experimental mice. 
the response of mice given only DNP-KLH. Thus, the difference between IgG 
and albumin cannot be attributed to a difference in their degree of substitution 
with DNP. 
Since the  duration of  tolerance induced by  2.5  rag/mouse  of  DNP-serum 
was less than 3 wk, it was of interest to determine if smaller doses of DNP-IgG DOV  THEO GOLAN AND  YVES BOREL  1053 
would  induce  tolerance of longer  duration.  A  group of seven mice was  pre- 
treated with 0.5  mg/mouse of DNP-7IgG 23  days before the  challenge with 
DNP-KLH. No response to DNP was detectable in these animals (mean PFC/ 
106 spleen cells,  3.0 4-  0.9). Thus a  single injection of 0.5  ml of lightly sub- 
stituted DNPT-IgG is as effective to maintain tolerance than two injections of 
2.5 nag of DNPwserum given 3 wk apart. 
The  Role  of Heterologous  Protein  Carriers  in  the Induction  of  Tolerance  to 
DNP.--Different groups of BDF1 mice were treated with DNP-HGG, DNP- 
RGG, DNP-BSA, or DNP-KLH. The results (Fig. 4) indicate that the induc- 
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FIO. 4. Induction  of tolerance  to  DNP  with  DNP  bound  to  heterologous protein  carriers. 
White column represents the geometrical mean of the number of direct PFC 4- s~. in control 
mice immunized with 0.2 mg of DNP62-KLH. The broken line represents the geometrical mean 
(including sE) of the number of direct PFC in animals immunized with 0.2 mg of KLH  only. 
The hatched columns represent the geometrical mean of the number of direct PFC 4- sz in 
groups of mice (4-6/group) pretreated intravenously with  DNP  bound  to  different heter- 
ologous  protein carriers:  DNP21-BSA,  DNP29-KLH, DNP22-HGG  (for  comparison the re- 
sults  obtained with DNP12-mouse IgG and DNPls-mouse albumin are given). All animals 
were challenged intraperitoneally with DNP-KLH immediately after pretreatment with the 
different DNP carrier conjugates. The vertical bar represents 1 SE. 
Bkg, background. 
tion of tolerance to the hapten is carrier dependent. Isogeneic carriers had a 
greater ability to induce tolerance to the hapten than any of the foreign car- 
riers tested. When the various conjugates were emulsified in CFA and tested 
for their  ability  to  initiate  an  immune  response to DNP,  only DNP-KLH 
and DNP-HGG had this ability. No correlation between the capacity of the 
conjugates  to  immunize  and  their  ability  to  induce  tolerance  was  found 
(Fig. 5). 
The Role of Synthetic Polypeptide Carriers  in  the Induction  of  Tolerance  to 
DNP.--Three  synthetic  homopolymers  of  lysine  coupled  with  DNP  [~- 
DNP-(lys)5,  a-DNP-(lys)g~,  a-DNP-(lys)31]  were  tested  in  the  following 
way  for  their  ability  to  induce  tolerance  to  DNP.  Three groups  of  BDF1 
mice were challenged with 0.2  mg of DNP62-KLH/mouse in  CFA  intraperi- PFC/IO  6 
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toneally. Starting 3  days  before  this,  each  mouse received four  daily intra- 
venous injections of  one of  the  DNP-homopolymers (0.25  mg/mouse, for  a 
total of 1 rag/mouse). A fourth group of mice was pretreated in the same way 
with DNPS not bound to a  carrier, and thereafter immunized with 0.2 mg of 
PFG/IO  6 
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FIG. 5.  Comparison  of  the  carrier  with  its  immunogenic  or  tolerogenic e2Tect. Left panel: 
White columns represent the geometrical mean of the number of direct PFC 4- sE of groups of 
mice  (4-6/group)  pretreated  intravenously with  various DNP  conjugates, 0.2  rag/mouse, 
and thereafter immunized with 0.2 mg/mouse of DNP 62-KLtt. Right panel: Hatched columns 
represent the geometrical mean of the number of direct PFC 4- SE of groups of mice (4-5/ 
group) that were immunized intraperitoneally with various DNP conjugates. The broken line 
represents geometrical mean of the direct PFC in animals immunized intraperitoneally with 
KLH alone. The vertical bars represent 1 sE. 
TABLE III 
Role of Synthetic Polypeptide  Carrier in the Induction  of Tolerance to DNP 
Tolerogen  No. of mice 
tolerant 
PFC/10~  (4- SE) 
Tolerant*  Nontolerant* 
--  --  --  100.0  (11.1) 
DNP  0/10  --  122.2  (18.6) 
a-DNP-(lys)5  3/10  27.7  (10.6)  91.1  (5.4) 
a-DNP-(lys)s~  7/10  7.9  (2.8)  90.4  (17.9) 
a-DNP-(lys)31  7/10  18.3  (5.8)  96.5  (16.3) 
* Tolerant and nontolerant animals were separated  by the 95% confidence limit of the 
control immunized animals, i.e., animals which were not within the 95% confidence limit of 
the control were said to be tolerant. 
DNP,2-KLH/mouse. A  fifth  and  control group  of  mice was  not  pretreated 
before immunization. The results are  summarized in Table III. Three out of 
10  mice  treated  with  a-DNP-(lys)5,  seven  out  of  10  treated  with  a-DNP- 
(lys)hU, and seven out of 10 treated with a-DNP-(lys)3z acquired  tolerance of 
DNP.  A  sixth group of  four mice  were injected intravenously with  1 mg of DOV  THEO  GOLAN  AND  YVES  BOREL  1055 
e-DNP-(Iys)1 before being challenged with DNP-KLH. This failed to induce 
tolerance (mean PFC/106  100.8  ±  28.0). 
The antigenic specificity of the tolerance to DNP was examined in the case 
of a-DNP-(lys)~.  Mice pretreated with  the  homopolymer conjugate for 4 
days were challenged simultaneously with DNP-KLH in CFA and HRBC in 
saline. A  control group of mice was immunized with DNP-KLH and HRBC, 
but  did not  receive the  a-DNP-(lys)k'7.4.  The results are presented  in Table 
IV,  which  shows  that  immunologic tolerance in  the  experimental mice was 
specific for a-DNP-(lys)~. 
Immunogenicity  of  the  Tolerogen.--The  immunogenicity  of  the  different 
tolerance-inducing substances  used  in  these  experiments was  tested by:  (a) 
TABLE IV 
Antigen Specificity of Tolerance to DNP 
Antigen  PFC/10s (-4- s~) 
No. of mice  Tolerogen 
DNP-KLH  HRBC  DNP  (PFC)  HRBC (PFC) 
3  --  +  +  68.6  (5.4)  145.7  (13.7) 
4  ot-DNP-(lys)~  +  +  15.1  (2.5)  150.5  (24.9) 
TABLE V 
Inability of the Tolerogens to Induce a Primary Response to DNP 
No. of mice  Challenge  PFC/10  6 (q- SE) 
9  DNPB2-KLH  99.9  (11.1) 
6  None  4.0  (0.6) 
5  a-DNP-(lys)s.4  4.2  (0.6) 
5  DNP23-MGG  1.9  (0.5) 
4  DNP12-MSA  6.3  (2.5) 
their  ability  to  induce  direct  PFC  when  injected in  CFA  and  (b)  by  their 
ability  to  induce  the  formation  of  circulating  antibodies  when  injected  re- 
peatedly in  CFA  into  BDF1  and  BALB/c mice.  Since  the  results  in  both 
strains were similar,  only the results obtained in BDF1 mice are mentioned. 
The results are summarized in Table V and Fig. 6 and 7. 
An inability to induce a primary response to DNP was a common feature of 
all the tolerogenic conjugates when the immune response was  tested by the 
hemolytic plaque assay (Table V). However, the various tolerogens differed in 
their ability to provoke an immune response when injected repeatedly. When 
tested by the modified Farr technique the sera of most of the animals had no 
anti-DNP antibody (Fig. 6). However, when the microhemagglutination tech- 
nique  was  used,  the  sera  of  mice  given  DNP-serum  and  DNP-C57BL/6J 
albumin  contained anti-DNP  antibodies in  moderately high  fiters. No  anti- 
body was detected in the sera of mice injected with polylysine conjugates, and 1056  NONANTIGENICITY  AND  IMMUNOLOGIC  TOLERANCE 
low titers of antibody were found in 2/5 animals hyperimmunized with DNP- 
C57BL/6J  IgG (Fig.  7). 
DISCUSSION 
These  results  show  that  when  mice receive  a  hapten  (DNP)  bound  to  a 
nonimmunogenic carrier, they are unable to respond to the same hapten when 
it is bound  to an immunogenic carrier (KLH). The unresponsiveness induced 
by treatment with  the nonimmunogenic hapten  carrier conjugate has all the 
characteristics of immunologic tolerance: it has a definite induction time; it is 
transient, but can be maintained by additional injections of the tolerogen; it is 
dose dependent; the unresponsiveness is highly specific for the hapten. Further 
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FIG. 6.  Radioactive  immunoassay  according  to  a  modification  of Fart's  technique.  30% 
binding should be considered the limit of the sensitivity of the technique, which can detect 
0.002 mg of antibody. Each sample was analyzed in duplicate for each group of I0 mice 
(except for the groups immunized with DNP-MSA and DNP-mouse gamma globulin (MGG), 
which have five mice each). 
more, as we will show elsewhere,  the tolerance of DNP can be transferred or 
abrogated  by lymphoid cells3 
It is widely held that tolerance can be induced  only by immunogenic sub- 
stances. This notion  has been previously challenged by Schechter et al., who 
found  that  rabbits pretreated  with  poly-DL-alanine, which  by itself is  non- 
hnmunogenic, are unresponsive to that polypeptide when it is bound either to 
HSA  or  ribonuclease  (11).  Ordinarily,  conjugates  of  poly-DL-alanine  with 
those  carriers  are  immunogenic  in  the  rabbit.  Similar  results  were  obtained 
by Maurer et al,  and Roelants and Goodman by using  the  nonimmunogenic 
polyglutamic  acid  to  induce  tolerance  (12,  13).  Poly-DL-alanine  was  sub- 
2  Borel, Y.,  U. Jehn, and D. T. Golan. Cellular cooperation in the induction of tolerance 
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sequently found to be immunogenic when certain conditions of immunization 
were used (14), and in our experiments DNP-isogeneic serum, which was non- 
immunogenic under conditions where it was tolerogenic, was weakly immuno- 
genic  when  administered  repeatedly  in  CFA.  The  difference between  im- 
munogenicity and nonimmunogenicity may thus be more apparent than real, 
and reflect only the mode of immunization and the sensitivity of the techniques 
used to reveal immunity. 
With  these limitations in mind, it seems that defined conjugates of DNP, 
such as a-DNP-(lys)5, a-DNP-(lys)k-7, and  o~-DNP-(lys)~l  are not immuno- 
genic in mice. Using two modes of immunization and three different methods 
of  antibody  detection,  we  found  no  anfi-DNP  antibodies  despite  repeated 
administration  of  these  conjugates  in  complete  Freund's  adjuvant.  These 
results confirm the work of Pinchuck and Maurer (15). What is of importance 
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FIG. 7. Passive hemagglutination test using  DNP 6o-BSA-coated  SRBC. Each point repre- 
sents individual results of each sample tested. 
is  that,  although  these substances were not immunogenic, they were  tolero- 
genic. With the reservation that nonimmunogenicity may merely be an opera- 
tional definition, this result implies that immunogenicity is not an obligatory 
requirement for the induction of immunologic tolerance. 
Collotti and Leskowitz, who studied tolerance in terms of delayed hyper- 
sensitivity in guinea pigs, concluded that immunogenicity is a requirement for 
the induction of tolerance (16). In other work,  a we found that DNP-(lys)5, 
which is nonimmunogenic in guinea pigs, failed to induce tolerance in terms of 
delayed  hypersensitivity  to  DNP-(lys)~,  which  is  immunogenic.  Several 
reasons may account for this apparent discrepancy. First,  the mechanism of 
suppression  of  delayed hypersensitivity and  antibody formation,  which  are 
different immunologic phenomena, may be different. Second, the suppression 
of delayed hypersensitivity and antibody formation may, under certain condi- 
tions,  be  mediated  by  different  antigenic  determinants  on  the  substance 
3  Borel, Y., and S. Schlossman. Unpublished observation. 1058  NONANTIGENICITY  AND  IMMUNOLOGIC  TOLERANCE 
inducing tolerance. Third, the difference between the two animal species used 
and  between  their  relative  degrees  of  immunological  maturity  might  also 
account for this discrepancy. 
The ability to induce tolerance of an antigen with a nonantigenic substance 
may permit separation of the phenomenon of tolerance from that of immunity. 
Other data showing that the part of the antigen against which antibody reacts 
in vitro is not the same as the part of the antigen responsible for the induction 
of tolerance in vivo, also support the notion that  these immunologic pheno- 
mena can be dissociated from each other (17). It is conceivable that tolerance 
and immunity involve different systems of cellular recognition. Whether the 
tolerogen and antigen compete for the same or different receptors on a single 
cell or on different cells is not known. 
Sela has suggested that  the part  of the antigen molecule that is most im- 
portant for antibody formation is not necessarily the most important for the 
induction  of  tolerance  (18).  According  to  him,  the  latter  property  of  the 
molecule may be strongly influenced by its carrier moeity. Our data illustrate 
this  point.  The  antibody produced by  animals  immunized  with  DNP  con- 
jugates is directed primarily at DNP; however, DNP alone or DNP bound to 
one  lysine is  ineffective in  inducing  tolerance  to  DNP.  By contrast,  I)NP 
bound  to  (lys)~,  (lys)8 and  (lys)31 are  tolerogens. In further contrast,  DNP 
bound  to KLH is an irmnunogen but a  poor tolerogen. Here we see a  clear 
example of the influence of the carrier on the induction of tolerance. In the case 
of a simple hapten such as DNP, we can conclude that its carrier determines its 
immunological properties:  lacking  a  carrier,  DNP  is  inmlunologically inert; 
when conjugated to immunogenic carriers such as KI.H or HGG, it is immuno- 
genic;  when  conjugated  to nonimmunogenic carriers,  like a-DNP-(lys)~ or 
isologous IgG, it is tolerogenic. Among the nonimmunogenic or poorly immuno- 
genic  carriers,  isogeneic IgG  appears  to  be  the  most  effective, not  only to 
induce tolerance to DNP but also to maintain it. 
An  inverse relation between antigenicity and  tolerogenicity has been sug- 
gested (13). This is supported by our finding that a  carrier, to which an in- 
dividual is naturally tolerant, has a  greater ability to induce tolerance to the 
hapten  than  foreign carriers.  It  has  also  been found that  animals  rendered 
tolerant to a carrier cannot respond to a hapten attached to it (19). However, 
this  apparent  inverse  relation  between  inlmunogenicity  and  tolerogenicity 
of the  conjugate does not  appear  to be a  general phenomenon as  shown  in 
Fig. 5. 
It is  of interest that among the various carriers tested, IgG was  the most 
tolea-ogenic  carrier.  A  similar  finding was  reported by Havas  (20).  Whether 
other serum proteins will also show this ability is not yet known. What accounts 
for the  difference among these molecules is not yet clear. Whatever the  ex- 
planation,  these data illustrate the importance of the selection of the carrier DOV  THEO  GOLAN  AND  YVES  BOREL  1059 
when attempting to induce tolerance to its haptenic moiety. This might explMn 
why other investigators were only partially successful in inducing tolerance to a 
hapten by treatment with these haptens conjugated to mouse serum albumin 
(MSA), BSA, or BGG (21, 22). 
It might not be fortuitous that a molecule known to be an antibody functions 
also  in  the  induction  of tolerance. Whether  or  not  this  property of IgG  is 
merely coincidental is  presently under  investigation.  It  is  conceivable that 
IgG plays some role in the induction or maintenance of tolerance. 
These findings have many implications, not only in approaching the under- 
standing of tolerance, but also in advancing a clinically feasible solution to the 
induction of tolerance. For example, it is not difficult to envision the induction 
of tolerance of tissue antigens by treatment of a prospective allograft recipient 
with purified histocompatibility antigens coupled to nonimmunogenic carriers. 
Whatever the results of such experiments will be, induction of tolerance with a 
nonimmunogenic substance allows the study of the cellular mechanism of this 
immunologic phenomenon in  the  absence of the  technically undesirable  im- 
mune response. 
SUMMARY 
Treatment  of  adult  mice  with  dinitrophenyl  (DNP)  bound  to  isogeneic 
serum resulted in a  specific inability to respond to DNP  after challenge with 
DNP-keyhole limpet hemocyanin (KLH) in complete Freund's adjuvant. The 
unresponsiveness  to  the  hapten  had  all  the  characteristics  of  immunologic 
tolerance: it had a definite induction time; it was transient but could be main- 
tained by additional injections of the tolerogen; it was antigen specific and dose 
dependent. In addition, the induction of tolerance to DNP is dependent on the 
nature of the carrier. 
Two main  conclusions can be drawn from these data:  DNP  conjugates of 
three homopolymers of lysine were found to be nonimmunogenic in mice, yet 
tolerogenic. Thus, antigenicity is not necessary to induce tolerance. 
Among the various carriers tested, isogeneic 7S immunoglobulin (IgG) was 
found to be the most effective to induce and maintain tolerance to the hapten. 
This suggests that IgG may have a function other than its usual role as an im- 
munoglobulin. 
The skillful technical assistance of Mrs. Lynne Kilham was greatly appreciated. 
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